Axsome Therapeutics (AXSM) announced on Wednesday that the U.S. FDA has granted priority review for its marketing application ...
Axsome Therapeutics’ AXSM lead drug, Auvelity (AXS-05), approved for treating major depressive disorder, has witnessed strong sales uptake since its approval and launch. Auvelity, the first approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback